3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Hodgkin Disease
1
Brain Neoplasms
1
Interventions
Filgrastim
4
Magnetic Resonance Spectroscopy
3
Dexamethasone
3
entrectinib
2
Vincristine
2
Temozolomide
2
Pemetrexed
2
Methylphenidate
2
Methods
2
Drug Therapy
2
Cytarabine
2
Cyclophosphamide
2
Carmustine
2
trametinib
1
sonidegib
1
selinexor
1
sargramostim
1
ribociclib
1
gadobutrol
1
gadobenic acid
1
entinostat
1
cc-486
1
carboxyamido-triazole
1
alovudine
1
alectinib
1
Zidovudine
1
Watchful Waiting
1
WP 744
1
Topotecan
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Genistein
×
Lymphoid
×
Clear all
NCT02624388
2024-05-06
UVA-Gen001
University of Virginia
Phase 2
Terminated
4 enrolled
16 charts